Prostate Cancer Progression Slowed By Avodart | ThirdAge

Links shared publicly online about this topic.

  • 483
    total visits

Prostate Cancer Progression Slowed By Avodart | ThirdAge

thirdage.com

Prostate cancer is a common concern for aging men, who after their thirtieth birthday, often have exams performed to check for the disease. While the diagnosis of prostate cancer often occurs in 30 or 40 year olds, it is much more common for those of us

View full resource at thirdage.com

Tags: Cancer, Prostate Cancer, Prostate, Benign Prostatic Hypertrophy Medication, Men's Health, Healthy Aging, Avodart

  • Share

Most Recently Shared on February 24, 2011 at 2:46 pm By:

thirdagetimes ThirdAge.com

Prostate Cancer Progression Slowed By Avodart http://bit.ly/dIwicu

1 year ago...

Drug May Slow Early Prostate Cancer: Study

health.yahoo.net — “TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on January 25, 2012 at 6:18 am By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/jUM5eixT

4 months ago...

Drug May Slow Early Prostate Cancer: Study - Yahoo! News

news.yahoo.com — “From Yahoo! News: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on January 24, 2012 at 2:42 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/cLzxFqhL

4 months ago...

ASCO GU: PCa Growth Slowed by 5-ARI - QualityPoint Technologies

qualitypointtech.net — “ORLANDO (MedPage Today) -- Men with early-stage prostate cancer had almost a 40% reduction in the risk of progression when treated with the drug dutasteride (Avodart) during active surveillance, according to data from a randomized trial.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on February 16, 2011 at 12:35 am By:

MedicalFeed MedicalFeed Health News Feed

ASCO GU: PCa Growth Slowed by 5-ARI: ORLANDO (MedPage Today) -- Men with early-stage prostate cancer had almost a ... http://bit.ly/g5RUlU

1 year ago...

Medical News: ASCO GU: PCa Growth Slowed by 5-ARI - in Meeting Coverage, ASCO GU from MedPage Today

medpagetoday.com — “ORLANDO -- Men with early-stage prostate cancer had almost a 40% reduction in the risk of progression when treated with the drug dutasteride (Avodart) during active surveillance, according to data froView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on February 16, 2011 at 12:04 am By:

Advertisement